Showing 481-490 of 10031 results for "".
Anti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.A Resurgence: Ablative Resurfacing
https://practicaldermatology.com/conferences/aad-summer-2021/a-resurgence-ablative-resurfacing/19977/Mask mandates, social distancing, and increased tolerance for downtime seem to have led to an uptick in ablative resurfacing. These procedures can offer dramatic results, but Arisa Ortiz, MD says it's important to select the right patients. Plus, she offers tips for post-care counseling to manage paCosmeceuticals: It's All About End Results
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceuticals-it-s-all-about-end-results/18582/End results separate the science from the marketing of topical cosmetic products, says Annie Chiu, MD. She talks about the challenges of formulating and preserving delicate ingredients and explains why packaging is so important. Patients need education about ingredients and packaging, she says, to oISDPA: Dr. Lio on Alternative and Innovative Approaches
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-lio-alternative-and-innovative-approaches/27066/Practical Dermatology Editorial Board member Peter Lio, MD, discusses the presentation that he and Tracee Blackburn, PA-C, gave about alternative and innovative approaches in dermatology, as well as the importance of educational engagement between physician assistants and dermatologists, at the IlliDWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Nothing Fishy: The Facts About Alternative Interventions for Skin
https://practicaldermatology.com/topics/psoriasis/nothing-fishy-the-facts-about-alternative-interventions-for-skin/19933/From fish oil to indigo naturalis, several agents may provide modest but reliable benefits that can enhance topical therapy for psoriasis. Similarly, coconut oil and sunflower oil may provide some benefit for eczema. Peter Lio, MD discusses the available data and potential use of these and other ageTaking Action: Quality of Care in AD
https://practicaldermatology.com/topics/atopic-dermatitis/taking-action-quality-of-care-in-ad/19881/Beyond identifying barriers to AD patient care, the Quality of Care in Atopic Dermatitis initiative presents potential solutions. Eric Simpson, MD, MCR outlines some key strategies for improving care and emphasizes that some simple steps can make a big difference.Chemical Peels for Lip Augmentation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/chemical-peels-for-lip-augmentation--dcwokite/19585/For patients looking for natural results or who want an alternative to hyaluronic acid fillers and needles, deep chemical peels are an excellent alternative for lip augmentation, explains Kachiu Lee, MD. She shares treatment pearls and discusses the kind of results patients can expect.Antibiotics and the Mutant Selection Window
https://practicaldermatology.com/topics/atopic-dermatitis/antibiotics-and-the-mutant-protection-window/19537/When considering antibiotics for treating acne, Hilary Baldwin, MD says there's a new concept dermatologists should consider in preventing antibiotic resistance. She describes the mutant selection window and why a higher dose antibiotic may actually be safer and more effective.ASDS Survey: 8 Million Procedures in 2012
https://practicaldermatology.com/topics/practice-management/asds-survey-8-million-procedures-in-2012/19259/"More and more people are seeking care from dermatologic surgeons." ASDS President Timothy Flynn, MD addresses new findings about the public's dependence on dermatologic surgeons. Derm surgeons' expertise and training in cosmetic and medical care are discussed.